Blood Pressure Meds on Watch
As researchers uncover link to cancer.
Get the Beast Digest newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
English scientists have discovered a connection between a popular form of blood pressure medication and cancer. A study of 60,000 people taking angiotensin-receptor blockers, or ARBs, showed a 1% increase in breast, prostate and lung cancer. While the risk is modest, it's statistically significant and could have outsize effects. "The risk for the individual patient is modest," said Dr. Ilke Sipahi, the main author of the study. "However, when you look at it from the population level, millions and millions of people are on these drugs and it can cause a lot of excess cancer worldwide." Sipahi says he's now more cautious to prescribe ARBs, though he realizes that the risk of not taking the medication far outweighs the chances of acquiring cancer for many patients. The company that manufactures Micardis, one of the brand names of the drug, has disputed these findings. Although researchers are not sure why the drugs increase cancer risk, tests on animals point toward the growth of new blood vessels, which could increase tumor growth.
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation